STAAR Surgical Company

STAA Healthcare Medical Instruments & Supplies

STAAR Surgical Company’s revenue for fiscal 2025 (year ended December 2025) was $239.4 million, down 23.7% from fiscal 2024.

Revenue
−12.0%
EPS
−38.9%
Free cash flow
+1,378.7%

Quarter to September 2026, against a year earlier

25.51 1.21 −4.53%
Market cap
$1.3B
P/E
0.0×
Fwd P/E
84.4×
Dividend yield
—
F-score
2/9
Altman Z
6.44
Beneish M
−3.29
Dividend safety
n/a

STAAR Surgical Company (STAA) P/E ratio

Alert me on P/E ratio

STAAR Surgical Company has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 1,540× (June 2018) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 0.0× —
FY2023 66.1× 3.13%
FY2022 64.1× (58.81%)
FY2021 156× (77.03%)
FY2020 677× 496.81%
FY2019 113× (62.99%)
FY2018 307× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 0.0× —
Jun 2026 410× —
Mar 2026 0.0× —
Dec 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 1,540×
Ten-year median 83.2×
Current reading's percentile 41

P/E ratio against peers

Company P/E ratio
KMTS Kestra Medical Technologies, Ltd. compare n/m
STAA STAAR Surgical Company n/m
ANGO AngioDynamics, Inc. compare n/m
AZTA Azenta, Inc. compare n/m
XRAY DENTSPLY SIRONA Inc. compare n/m
LMAT LeMaitre Vascular, Inc. compare 29.7×
ATRC AtriCure, Inc. compare 199×
WRBY Warby Parker Inc. compare 434×
NNNN Anbio Biotechnology compare —
Medical Instruments & Supplies industry median 30.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on STAA